Natalizumab in secondary progressive multiple sclerosis

被引：3
|
作者：
Edan, Gilles [1 ]
机构：
[1] CHU Pontchaillou, INSERM, CIC1414, F-35033 Rennes, France
来源：
LANCET NEUROLOGY | 2018年 / 17卷 / 05期
关键词：
MS;
D O I：
10.1016/S1474-4422(18)30108-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [21] Defining secondary progressive multiple sclerosis
    Lorscheider, Johannes
    Buzzard, Katherine
    Jokubaitis, Vilija
    Spelman, Tim
    Havrdova, Eva
    Horakova, Dana
    Trojano, Maria
    Izquierdo, Guillermo
    Girard, Marc
    Duquette, Pierre
    Prat, Alexandre
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Grammond, Pierre
    Hupperts, Raymond
    Alroughani, Raed
    Sola, Patrizia
    Boz, Cavit
    Pucci, Eugenio
    Lechner-Scott, Jeanette
    Bergamaschi, Roberto
    Oreja-Guevara, Celia
    Iuliano, Gerardo
    Van Pesch, Vincent
    Granella, Franco
    Ramo-Tello, Cristina
    Spitaleri, Daniele
    Petersen, Thor
    Slee, Mark
    Verheul, Freek
    Ampapa, Radek
    Amato, Maria Pia
    McCombe, Pamela
    Vucic, Steve
    Sanchez Menoyo, Jose Luis
    Cristiano, Edgardo
    Barnett, Michael H.
    Hodgkinson, Suzanne
    Olascoaga, Javier
    Laura Saladino, Maria
    Gray, Orla
    Shaw, Cameron
    Moore, Fraser
    Butzkueven, Helmut
    Kalincik, Tomas
    BRAIN, 2016, 139 : 2395 - 2405
  • [22] Defining secondary progressive multiple sclerosis
    Lorscheider, Johannes
    Buzzard, Katherine
    Jokubaitis, Vilija
    Spelman, Tim
    Lechner-Scott, Jeannette
    McCombe, Pam
    Vucic, Steve
    Barnett, Michael
    Butzkueven, Helmut
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (14) : NP15 - NP15
  • [23] Primary and secondary progressive multiple sclerosis
    Vukusic, S
    Confavreux, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) : 153 - 155
  • [24] Parkinsonism Secondary to Progressive Multiple Sclerosis
    Soto, Arnoldo
    Gallardo, Marisol
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1856 - 1857
  • [25] The lymphocyte subpopulation in patients with primary progressive multiple sclerosis and secondary progressive multiple sclerosis
    Belniak, Ewa
    Bojarska-Junak, Agnieszka
    Bartosik-Psujek, Halina
    Mitosek-Szewezyk, Krystyna
    Kulka, Malgorzata
    Stelmasiak, Zbigniew
    Rolinski, Jacek
    MULTIPLE SCLEROSIS, 2008, 14 : S116 - S116
  • [26] Dynamic of neurofilament light chains after cessation of natalizumab in patients with relapsing remitting and secondary progressive multiple sclerosis
    Proschmann, U.
    Akguen, K.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 482 - 482
  • [27] Effect of natalizumab in patients with progressive forms of multiple sclerosis and high disability
    Petrou, P.
    Vaknin-Dembinsky, A.
    Abramsky, O.
    Ben-Hur, T.
    Karussis, D.
    JOURNAL OF NEUROLOGY, 2011, 258 : 255 - 255
  • [28] Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy
    Eisele, Philipp
    Szabo, Kristina
    Hornberger, Eva
    Griebe, Martin
    Hennerici, Michael G.
    Kieseier, Bernd C.
    Gass, Achim
    JOURNAL OF NEUROIMAGING, 2014, 24 (04) : 425 - 428
  • [29] NATALIZUMAB IN MULTIPLE SCLEROSIS
    Rio-Izquierdo, J.
    Montalban, X.
    REVISTA DE NEUROLOGIA, 2009, 49 (05) : 265 - 269
  • [30] Natalizumab and multiple sclerosis
    Vellutini Pimentel, Maria Lucia
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (03) : 135 - 136
12345